Abbott Receives Regeneron Treatment After COVID Diagnosis
After yesterday’s announcement that Gov. Greg Abbott tested positive for COVID-19, his office said he was receiving Regeneron’s monoclonal antibody treatment. According to the U.S. Food and Drug Administration, this is a one-time treatment that is administered intravenously. The drug is a combination of two antibodies that can fight off the virus before it has a chance to take hold and do more damage.
According to a report by Bloomberg, recent data shows this treatment cuts the risk of hospitalization or death by roughly 70 percent in high-risk patients, and can reduce the chance of infection among a patient’s household members by more than 80 percent. However, it cannot be used on patients who are already hospitalized with COVID-19 or on oxygen therapy.
The FDA says Regeneron’s antibody treatment is not a substitute for vaccination against COVID-19 and still urges all eligible people to get vaccinated.
Abbott received the Pfizer vaccine last December and reports no signs of COVID-19 symptoms so far. He is quarantined in the governor’s mansion in Austin.
Lisa Brown has decades of experience in corporate communications and marketing management with organizations including Coldwell Banker Residential, Grubb & Ellis, Marcus & Millichap, NAIOP, SIOR and ALM.
In those positions, she worked in conjunction with chief executive officers and chief marketing officers to create corporate messaging, cohesive branding standards, strategic marketing plans and thought pieces. Brown is a frequent speaker at industry events and an editing adjunct professor for an online course. She has a master’s degree in mass communications from San Jose State University.
CRE courses for CE credits
Get CE course credits, centered around all things CRE. View our courses today!